Abstract
Due to imperfect discrimination against ribonucleoside triphosphates by the replicative DNA polymerases, large numbers of ribonucleotides are incorporated into the eukaryotic nuclear genome during S-phase. Ribonucleotides, by far the most common DNA lesion in replicating cells, destabilize the DNA, and an evolutionarily conserved DNA repair machinery, ribonucleotide excision repair (RER), ensures ribonucleotide removal. Whereas complete lack of RER is embryonically lethal, partial loss-of-function mutations in the genes encoding subunits of RNase H2, the enzyme essential for initiation of RER, cause the SLE-related type I interferonopathy Aicardi-Goutières syndrome. Here we demonstrate that selective inactivation of RER in mouse epidermis results in spontaneous DNA damage and epidermal hyperproliferation associated with loss of hair follicle stem cells and hair follicle function. The animals developed keratinocyte intraepithelial neoplasia and invasive squamous cell carcinoma with complete penetrance, despite potent type I interferon production and skin inflammation. These results suggest that compromises to RER-mediated genome maintenance might represent an important tumor-promoting principle in human cancer.
Introduction
Genome integrity is continuously challenged by a multitude of different hazards that cause a broad spectrum of different lesions in DNA [1]. Spontaneous hydrolysis, ionizing radiation, exogenous chemicals and endogenous metabolites, including reactive oxygen species, inflict cumulative damage to DNA [1]. Fortunately, various DNA repair pathways revert most of this damage, thereby dramatically slowing down age-related deterioration of DNA integrity and suppressing the development of cancer [2]. In addition to continuous, time-dependent harm to DNA, other forms of damage are introduced already during replication by errors the replicative polymerases make, despite their remarkable fidelity. Such replication errors include incorporation of deoxyribonucleotides that are not complementary to the template, which occurs every 104-106 bases, depending on the DNA polymerase. Most mismatched nucleotides are removed by the proofreading activity that some DNA polymerases possess, while the remaining mismatches are detected and corrected by DNA mismatch repair (MMR), which is directly coupled to the replication machinery [3–5]. Postreplicative mismatch repair is an important tumor-suppressive principle as genetic defects in MMR proteins cause cancer predisposition syndromes, including Lynch syndrome [6] and biallelic mismatch repair deficiency (BMMRD) syndrome [7].
Another form of replication error is the incorporation of nucleotides containing the correct base, but the wrong sugar. For example, discrimination between incoming deoxyribonucleotides (dNTPs) and ribonucleotides (rNTPs) is imperfect for the three DNA polymerases that replicate the vast majority of the undamaged eukaryotic nuclear genome [8], resulting in frequent incorporation of rNMPs into genomic DNA [9, 10]. The probability for this mistake is increased by the far greater cellular abundance of rNTPs compared to dNTPs [8, 11] such that on average, more than 106 rNMPs are incorporated during one round of replication of a mammalian genome [12]. Newly incorporated rNMPs destabilize DNA [10] and pose a major threat to genome integrity due to their reactive 2’OH group. A highly conserved repair pathway, ribonucleotide excision repair (RER), ensures their removal [10, 13, 14]. Like MMR, RER may be directly coupled to replication and results in rapid postreplicative repair of rNMPs. The first step in RER is detection of rNMPs embedded in the DNA double helix by ribonuclease H2 (RNase H2). RNase H2 then incises the rNMP-containing strand immediately 5’ of the rNMP. In vitro, this is followed by strand displacement synthesis by polδ or polε, flap cleavage by Fen1 or Exo1 and ligation of the nick[14]. Interestingly, during their brief transient presence in DNA, rNMPs seem to serve important physiological functions in DNA metabolism [8, 13, 15]. They may provide a strand discrimination signal in MMR for the nascent leading strand [16, 17], wherein RNase H2-mediated incisions, occurring only in the newly synthesized rNMP-containing strand may serve as entry points for MMR enzymes. Moreover, nicking by RNase H2 could be crucial for relaxing leading strand torsional stress [18]. rNMPs might also be incorporated during repair synthesis occurring in non-cycling cells that contain very high rNTP:dNTP ratios.
RNase H2-deficient cells are incapable of executing normal RER, carry high numbers of rNMPs in their DNA and spontaneously mount a DNA damage response (DDR), reflecting the DNA-destabilizing effects of rNMPs (reviewed in [13, 15, 19]). rNMPs alter DNA structure and thereby potentially affect multiple key DNA transactions. rNMPs increase the rate of spontaneous hydrolysis and were shown to trigger a mutagenic repair pathway in yeast depending on DNA topoisomerase 1, which, like RNase H2, can incise at single rNMPs, potentially generating unligatable ends in repetitive DNA that result in short deletion mutations [20]. Topoisomerase 1 cleavage at ribonucleotides embedded in the DNA can also result in double strand breaks and replication stress ensuing from abnormally long-lived topoisomerase 1-DNA complexes [21]. Moreover, bypassing rNMPs in DNA may pose a problem for replicative polymerases, that may result in replication fork stalling, strand breaks and replicative stress. In addition to genome protection by RNase H2-mediated removal of single rNMPs, RNase H2 contributes to genome stability also by resolution of R-loops [22], preventing damage resulting from collisions of RNA polymerases or replication forks with R-loops.
Loss of RNase H2 causes genome instability in yeast with high rates of gross chromosomal rearrangements and copy number variations (reviewed in [13]). Mammalian cells lacking the enzyme display increased numbers of strand breaks, activation of DNA damage responses (DDRs), and chromosomal aberrations [12, 23]. Abnormal mitotic chromosome segregation associated with this damage was shown to occur in RNase H2-deficient cells, leading to formation of micronuclei [24, 25]. Similarly, DNA damage can lead to herniation of chromatin into the cytosol [26]. Micronuclei and herniated chromatin expose large amounts of chromosomal DNA to the cytosolic DNA sensor cGAS that activates STING and thereby triggers an inflammatory response, including upregulation of interferon-stimulated genes (ISGs) and inflammatory cytokine production [24]. Unbalanced type I IFN responses are likely responsible for chronic inflammation in patients suffering from the rare monogenic autoimmune disorder Aicardi-Goutières syndrome (AGS), which can be caused by partial loss of function of RNase H2 or by mutations in other enzymes involved in nucleic acid metabolism [27, 28].
In mouse models, the effects of targeted inactivation of RNase H2 in vivo were found to critically depend on the degree to which RNase H2 activity was reduced. The RNase H2 complex is composed of three proteins, RNASEH2A, B and C all of which are essential for RNase H2 activity [29, 30]. Biallelic null or hypomorphic mutations in RNase H2 genes that cause massive reduction of activity resulted in embryonic or perinatal lethality associated with spontaneous DNA damage and activation of DDRs [12, 23, 31]. In contrast, a homozygous mutation reducing RNase H2 activity to about 30% of wildtype levels triggered a spontaneous low level IFN response, but was not associated with gross pathology [32].
To elucidate consequences of severe RER deficiency for the homeostasis of a tissue with rapid cell turnover in adult animals, we bypassed embryonic lethality of ubiquitous RNase H2 deficiency by conditional gene inactivation. We demonstrate that complete loss of RNase H2 in skin epithelium results in spontaneous DNA damage and epidermal hyperproliferation that progresses to skin cancer with 100% penetrance, despite potent spontaneous type I IFN responses, demonstrating that RNase H2-dependent RER is an important tumor-suppressive principle.
Material and Methods
Mice.
Rnaseh2bFL/FL [23], K14-Cre [33], Ifnar1−/− (generated from Ifnar1FL mice [34] by ubiquitous deletion of the loxP-flanked fragment), Trp53−/− [34] were either on the C57BL/6NJ background or backcrossed for at least five generations to C57BL/6NJ. Mice were housed at the Experimental Center, Medical Faculty Carl Gustav Carus, TU Dresden, under specific pathogen-free conditions. All procedures were in accordance with institutional guidelines on animal welfare and were approved by the Landesdirektion Dresden (permit number 24–1/2013–12).
Quantification of mRNAs by quantitative RT-PCR.
Total RNA was isolated using the NucleoSpin kit (Macherey-Nagel) according to the manufacturer’s instructions. cDNA was generated using the RevertAid H Minus First Strand cDNA Synthesis kit (Thermo Fisher Scientific). Quantification of transcripts was performed on a Mx3005P QPCR system (Agilent Technologies) using the Maxima SYBR green/ROX qPCR Master Mix (Thermo Fisher Scientific). The following oligos were used: Oasl1 up, 5’-GCAATCCACAGCGATATCC-3’; Oasl1 down, 5’-CAACTGCTCACTGTCCACGG-3’; Ifi44 up, 5’-GAGTCACTCATTCTCGGACTCCGC-3’; Ifi44 down, 5’-GAGCGGGCATTGAAGTAAGGGC-3’; Viperin up, 5’-TTCGCCCGCATCAAAGCCGT-3’; Viperin down, 5’-AGGGGGCAGCGGAAGTCGAT-3’; Rnaseh2b up, 5’-AGGTTTCCAGGGACAAGGAAGAGGA-3’; Rnaseh2b down, 5’-GTCAATGAAGCTGGAGGTTCTGGAAG-3’; Tbp1 up, 5’-TGACCCAGATCATGTTTGAGACCTTCA-3’; and Tbp1 down, 5’-GGAGTCCATCACAATGCCTGTGG-3’. All samples were run in triplicates. qRT-PCR data are displayed as fold change compared to means of the respective control groups ± SD.
Assay for RNase H2 activity.
Cell lysates were prepared and assayed for specific cleavage of an 18-bp double-stranded DNA substrate containing a single ribonucleotide in one strand as previously described [27, 29]. RNase H2–specific activity was determined by subtracting the cellular activity against a sequence-matched DNA duplex without ribonucleotides. Cell lysate protein concentration was determined and lysates were added to the reaction mix at a final protein concentration of 100 ng/μl.
Isolation and flow cytometric analysis of epidermal cells.
Back skin was excised and adipose tissue was removed. The skin was placed on a layer of trypsin solution (0.25%, Life Technologies Germany) with the epidermal side facing upwards. After incubation for 2 hours, the epidermis was separated from the dermis using blunt forceps. The epidermis was minced with scalpels and digested in 10 ml trypsin solution (0.25%, Life Technologies) for another hour. The digest was stopped by adding an equal volume of medium (DMEM (2/3) + HAM`s F12 (1/3)) supplemented with 10% calcium free FBS and the cells were strained through a 40 μm nylon mesh. Cells were then centrifuged for 8 min at 500 g at RT and the pellet was resuspended in 2 ml FACS buffer. Epidermal stem cell populations were stained according to Jensen et al. [35]. For flow cytometry, cells were stained using the following antibodies: anti-CD45-FITC (1:400, eBioscience), anti-CD49f-PE (1:200, eBioscience), anti-CD34-eF660 (1:50, eBioscience), anti-Sca1-PerCP-Cy5.5 (1:200, eBioscience), anti-CD117-APC-Cy7 (1:800, Biolegend). Cell sorting and analysis was performed on an ARIA III cell sorter (BD) and data were recorded using DIVA software (BD) and analyzed using FlowJo (FlowJo, LLC).
Transcriptome analysis.
Keratinocytes (CD49f+) and hematopoietic cells (CD45+) were isolated from skin cell suspensions by FACS (see above). Total RNA was isolated using the RNeasy Mini Kit+ (Qiagen). mRNA libraries were prepared and subjected to deep sequencing on an Illumina®HighSeq. Reads were mapped to the reference genome mm10 (Ensembl Version 75) using gsnap (v.2014–12-06 for analysis of CD45−CD49f+ cells, v.2014–12-17 for analysis of CD45+ cells) and genes were counted with featurecount v.1.4.6.. Differentially expressed genes (DEGs) were identified using DESeq2 v1.8.1 [36]. Custering of DEGs into specific pathways was investigated using KEGG (http://www.ge-nome.jp/kegg/pathway.html), Reactome (https://reactome.org/) and Interferome V2.0 (www.interferome.org/) databases as well as the Ingenuity Pathway Analysis (IPA) software (Qiagen). RNA-seq data reported in this paper are accessible as a super series from the Gene Expression Omnibus database (GEO) under accession number GSE115005.
Histology.
Formalin-fixed and paraffin-embedded skin sections were de-paraffinized and rehydrated, subjected to antigen retrieval (20 min 98°C in sodium citrate pH 6.0) and washed three times in TBST (1×TBS, 0.1% Triton X-100).
For quantification of phosphorylated histone H2A.X (γH2A.X), sections were blocked for 1h (10% goat serum in TBST) and incubated at 4°C over night with a phospho-histone H2A.X (pSer139) antibody (Cell Signaling, 1:50 in 1% goat serum/tris-buffered saline with 0.05% Tween20 (TBST)). Next, sections were washed (TBST) and incubated with a goat anti-rabbit-AF488 antibody (1:500, Thermo Fisher Scientific) for 4h at room temperature in the dark. After washing, nuclei were counterstained with DAPI in the mounting solution. Images were recorded on a Zeiss Axiovert ApoTome II and analyzed using Zen® software (Zeiss). γH2A.X foci in at least 220 keratinocyte nuclei of the interfollicular epidermis per section were counted.
For quantification of Ki67-positive cells, endogenous peroxidase activity was blocked (3% H2O2, 20 min in the dark), unspecific epitopes were blocked (PBS 10% BSA, 0.5% Triton X-100 for 1h at room temperature) and sections were washed and incubated at 4°C over night with anti-Ki67-Biotin (eBioscience, 1:100 in PBS 1% BSA, 0.05% Triton X-100). After washing, sections were incubated for 1h at RT with HRP-conjugated Streptavidin (Dako, 1:300, PBS, 1% BSA, 0.05% Triton X-100). After addition of DAB mix (Vector Labs) and counter-staining with hematoxylin, Ki67-positive keratinocytes were counted in interfollicular epidermis.
For quantification of dying cells positive for activated caspase 3, antigen retrieval was performed in PBS with 1 mM EDTA, 0.05% Tween 20, pH 8.0 for 20 min in a pressure cooker), sections were blocked (PBS, 0.1% Tween 20, 5% normal goat serum) and incubated with rabbit anti-active-Caspase3 AF835 (R&D, 1:600) at 4°C over night, followed by washing and incubation for 1h at RT with goat anti-rabbit AF488 (ab150077, Abcam, 1:500). Nuclei were stained with DAPI. Images were recorded on a Keyence BZ-X710 microscope and positive cells were counted in interfollicular epidermis and follicular infundibula.
Histological evaluation was performed by a professional dermato-histopathologist (J. Wenzel, Bonn, Germany) in a blinded fashion.
Statistical analysis.
Unless stated otherwise, significance was calculated by unpaired, two-sided Student’s t-test, *** P<0.001, **P<0.01, *P<0.05.
Results
1. Complete loss of RNase H2 in the epidermis results in epithelial hyperproliferation and loss of stem cells
We inactivated the Rnaseh2b gene selectively in the epidermis by crossing Rnaseh2bFLOX mice[23] to the K14-Cre line that deletes loxP-flanked DNA in all basal cells of skin epithelium including hair follicles [23, 33]. Rnaseh2bFL/FLK14-Cre mice (‘Rnaseh2EKO’ mice) showed strong reduction of Rnaseh2b transcripts and RNase H2 activity in total epidermis or FACS-purified epidermal cells, as expected (Fig. S1a, b, c). The animals were conspicuous already few days after birth, showing significant hyperpigmentation, most prominently of ears, snout, tails and paws (Fig.1a), a known sign of ongoing DNA damage responses in mouse epidermis[37, 38]. While whiskers were hypomorphic and reduced in number already in young mice (Fig.1a), the fur initially appeared macroscopically normal. However, Rnaseh2EKO mice began to loose hair at about 12 weeks and were almost completely nude by 20 weeks (Fig.1a).
Histologically, Rnaseh2EKO epidermis was normal at the age of 5 weeks except for discrete hyperkeratosis (thickening of the cornified layer). In older animals (10–13 weeks and 18–21 weeks), focal thickening of the epithelium and moderate hyperkeratosis suggested increased epithelial proliferation (Fig.1b). Immunostaining for the cell cycle marker Ki67 (Fig.1b) revealed increased numbers of proliferating epithelial cells in Rnaseh2EKO compared to control skin in all age groups tested. More rapid proliferation was paralleled by a strong increase in the frequency of apoptotic keratinocytes as detected by staining for active caspase 3 (Fig.1c, d). Loss of hair follicles did not account for the almost complete boldness of Rnaseh2EKO mice as substantial numbers of follicles were still present even at 30 weeks of age (Fig.S1d). In their active (anagen) phase, hair follicles grow to extend well into the dermal adipose tissue paralleled by thickening of the adipose tissue, whereas resting (telogen) follicles are usually confined to the dermal collagen layer. Numbers of anagen follicles were not different from control numbers at 5 weeks of age. At 10–13 weeks, we found no follicles extending into the adipose layer in control skin, indicating a synchronous resting phase of the hair cycle in this part of the body. In contrast, all Rnaseh2EKO mice featured numerous ‘active’ follicles at this time point, demonstrating disturbed hair cycle regulation (Fig.1e). This was also reflected by increased thickness of Rnaseh2EKO skin at 10–13 weeks as determined by skin fold measurements (Fig.S1e). Loss of hair follicle function in older Rnaseh2EKO mice suggested exhaustion of epithelial regenerative capacity. In accordance with this notion, we found that the number of hair follicle stem cells, in particular bulge stem cells (CD49f+CD34+Sca1lo) was strongly reduced in older mutants compared to controls, as determined by flow cytometric analysis of epidermal single cell suspensions (Fig.1f and S1f). In contrast, other undifferentiated epidermal cell populations were not reduced in mutant skin (Fig.1f and S1f).
Collectively, loss of RNase H2 in the epidermis results in more rapid epithelial cell turnover due to enhanced epithelial cell proliferation and apoptosis, associated with reduction of hair follicle stem cell numbers and loss of hair follicle function.
2. Spontaneous type I IFN response and inflammation in Rnaseh2EKO skin
Histology and flow cytometry revealed enhanced leukocyte infiltration of Rnaseh2EKO skin (Fig.2a,b), which was accentuated around hair follicles (Fig.2a). Inflammatory cell invasion into the epithelium was associated with degeneration of the outer-most epithelial cells of the hairfollicle (Fig.2a), an inflammation pattern (‘interface dermatitis’) typical of skin lesions in SLE [39].
Since RNase H2-deficiency was shown to be associated with spontaneous activation of type I IFN responses [31, 32], we quantified transcript levels of type I IFN-inducible genes (ISGs) in Rnaseh2EKO and control skin by qRT-PCR analysis. ISG mRNAs were strongly increased in total epidermis and in purified keratinocytes from young and older mutant mice (Fig.2c, Fig.S2a). Comparison of transcriptomes of leukocytes from control versus Rnaseh2EKO skin showed upregulation of multiple ISGs in the cells from the mutants, indicating exposure to type I IFN (Fig.2d, Table S1).
Type I IFNs were shown to regulate stem cell function in the hematopoietic system [40]. We therefore addressed what role the chronic IFN response in Rnaseh2EKO epidermis played and crossed Rnaseh2EKO mice to a type I IFN receptor knock out (Ifnar1−/−) line [41] (Fig.S2b). Hyperpigmentation, hair loss (Fig.2e), hyperkeratosis and focal epidermal thickening (Fig.S2c), and inflammatory leukocyte infiltration (Fig.2f) of Rnaseh2EKO skin were not mitigated by additional inactivation of type I IFN signaling. Rnaseh2EKOIfnar1−/− mice showed a reduction of hair follicle stem cell numbers compared to controls (Fig.2g), similar to IFNAR-competent Rnaseh2EKO mice (Fig.1e).
Collectively, the skin inflammation of Rnaseh2EKO mice is associated with type I IFN production, however, leukocyte infiltration, epidermal hyperproliferation and loss of hair follicle function occur independent of type I IFN.
3. Loss of RNase H2 in the epidermis results in spontaneous DNA damage and skin cancer
Spontaneous DNA damage and activation of DNA damage responses was shown in RNase H2-deficient embryos and cells [12, 23]. Moreover, the hyperpigmented skin of Rnaseh2EKO mice is suggestive of chronic DNA damage responses in the epidermis [37, 38]. Immunostaining of skin sections for γH2AX and 53BP1 repair foci indeed revealed increased numbers of γH2AX and 53BP1 foci in Rnaseh2EKO compared to control epidermal cells (Fig.3a, Fig.S3a), consistent with increased frequencies of double-strand breaks in RNase H2-deficient yeast [21]. In line with this finding, transcriptome analysis of flow cytometrically purified Rnaseh2EKO keratinocytes showed up-regulation of several p53-inducible genes compared to control cells (Fig.3b, Table S2), indicating ongoing DNA damage responses.
Starting from week 12, Rnaseh2EKO mice develop chronic ulcerations of the skin, most frequently in the dorsal neck area, affecting most animals by the age of 1 year (Fig.3c). All Rnaseh2EKO mice had to be sacrificed between 23 and 55 weeks of age due to these ulcerations, and/or because of large tumors in various locations, often in the mandibular region close to the ear (Fig.3c). Histology revealed (Fig.3d, Table S3) that all ulcerations occurred in neoplastic skin that was classified keratinocyte intraepithelial neoplasia (KIN) [42], i.e. malignant epidermal growth that has not yet breached the epithelial basement membrane, also called ‘carcinoma in situ’. In three of these cases, the tumor had focally broken through the basement membrane and was thus classified invasive squamous cell carcinoma (SCC). All macroscopic tumors histologically proved to be invasive SCC, except for two, which were KIN producing large masses of cornified material (Fig.3d, Table S3). Fig.Figure 3e shows that 100% of Rnaseh2EKO mice developed cancer of at least the KIN stage by about 50 weeks of age. By this time, 60% of the animals had already progressed to invasive SCC (Fig.3e). Additional inactivation of type I IFN signaling resulted in a slight (albeit insignificant) acceleration of neoplastic skin ulceration (Fig.S3b), most likely reflecting loss of stimulation of anti-tumor immunity by type I IFN.
Collectively, we show that RNase H2-deficient hyperproliferative epidermis features spontaneous DNA damage as demonstrated by increased numbers of repair foci and increased transcript levels of p53-inducible genes, and progresses to cancer in 100% of the animals within the first year of life.
4. Additional loss of p53 in Rnaseh2EKO mice enhances the epidermal IFN response and accelerates hyperproliferation and carcinogenesis
In order to determine the effect of p53-dependent DNA damage responses on the Rnaseh2EKO phenotype, we crossed Rnaseh2EKO to Trp53−/− mice [34] and observed potent effects of Trp53 gene dose. Rnaseh2EKO mice heterozygous for the Trp53null allele showed ameliorated hyperpigmentation compared to p53-competent controls (Fig.S4a) and no sign of alopecia until the age of 40 weeks. All Rnaseh2EKO Trp53+/− mice that were allowed to age had to be sacrificed because of macroscopic ulcerations or skin tumors before the age of 40 weeks. Histology showed that these lesions were invasive SCC of various stages and grades (Table S4, Fig.4a).
Biallelic loss of Trp53 completely reverted the hyperpigmentation of Rnaseh2EKO (Fig.4b, Fig.S4a). While no generalized alopecia was observed, all of these animals developed inflamed lesions associated with circumscribed loss of hair and extensive scratching in the neck area, starting at about 12 weeks of age (Fig.4b). Massive pruritus and erosions of the neck skin invariably required euthanasia few weeks later. In all cases, histology identified KIN of different stages as the cause of the lesions (Fig.4c, Tables S5 and S6). Ki67 immunostaining showed the massive proliferation of cells in all strata of the epithelium typical of KIN (Fig.4d). Inactivation of p53 signaling resulted in survival of more cells with a higher damage load as demonstrated by immunostaining for γH2AX repair foci (Fig.4e, Fig.S4b) as compared to p53 competent Rnaseh2EKO skin (Fig.3a). Flow cytometric analysis of Rnaseh2EKOTrp53−/− skin revealed that the loss of hair follicle stem cells caused by epidermal RNase H2 deficiency was prevented by lack of p53. Interestingly, hair follicle stem cell numbers of Rnaseh2EKOTrp53−/− epidermis ranged about 3-fold higher compared to control numbers (Fig.4f).
Compared to p53-competent Rnaseh2EKO mice, leukocyte infiltration was more pronounced in Rnaseh2EKOTrp53−/− skin (Fig.S4c). A potential reason for enhanced skin inflammation of these animals might be potentiated cytokine responses as we found strongly increased ISG mRNA levels in total epidermis and in keratinocytes of Trp53−/− as compared to p53-proficient Rnaseh2EKO mice (Fig.4g), demonstrating that p53-dependent DNA damage responses control the intensity of the STING-induced IFN response mounted by RNase H2-deficient keratinocytes. While we have shown that type I IFN was not causing the inflammation of Rnaseh2EKO skin (Fig.2f), STING-mediated, NFκB-dependent proinflammatory cytokine expression, triggered in parallel to the IFN response, could be responsible for the enhanced inflammation of IFNAR-deficient Rnaseh2EKO skin.
In summary, cancer development in Rnaseh2EKO mice is accelerated by additional absence of p53. This finding demonstrates that p53-dependent elimination of epithelial cells with high damage load potently antagonizes oncogenic transformation of RNase H2-deficient epidermis.
Discussion
DNA polymerases do not replicate genomic DNA without mistakes. They incorporate nucleotides carrying the wrong base or wrong sugar at substantial rates. In order to ensure genome integrity, two DNA repair pathways operate on the newly synthesized strand to correct these replication errors. MMR, which removes nucleotides that do not base-pair correctly with the template strand, and RER, which removes ribonucleotides, that are incorporated into the genomic DNA at a rate of 1 every 7,600 nucleotides [12] and threaten genome stability. Humans and mice with genetic defects causing loss of mismatch repair activity are viable but exhibit strongly increased cancer risk [6, 7, 43]. Genetic defects of RER leading to inability to remove ribonucleotides from genomic DNA result in embryonic lethality in the mouse [12, 23] and most likely also in humans, as partial loss of function mutations of the genes encoding RNase H2, the enzyme essential for initiation of RER, can result in severe disease and biallelic complete null alleles have not been found [44].
We bypassed embryonic lethality of global RER deficiency by conditional inactivation of the Rnaseh2b gene only in the epidermis of the skin and observed spontaneous DNA damage and epithelial hyperproliferation, resulting in spontaneous cancer development in 100% of the animals within the first year of life. Thus, we showed that RER is essential to prevent malignant transformation.
While the epithelium proliferated rapidly, it featured a high rate of keratinocyte apoptosis induced by p53 activation. Cancer development driven by epidermal RER deficiency was accelerated upon additional loss of one allele of the Trp53 gene. In Rnaseh2EKO mice harboring two Trp53 null alleles, the skin of neck and back transformed into one large confluent carcinoma in situ between 10 and 20 weeks of age. It seems likely that this process would have affected the entire skin and would have rapidly progressed to invasive SCC with increasing age, if not for the fact that the animals had to be euthanized for severe itch and erosions.
Carcinogenesis triggered by defective RNase H2 seems to require reduction of RNase H2 activity to low levels. Mice in which RNase H2 activity was reduced to 30% of control levels due to a homozygous Rnaseh2b partial loss-of-function mutation showed spontaneous activation of type I IFN responses but no sign of cancer by the age of 1 year [32]. Likewise, mice that carried a biallelic knock in of a Rnaseh2a partial loss-of-function mutation, reducing RNase H2 activity to few percent of normal levels, and that were rescued from perinatal lethality by additional inactivation of STING were not reported to develop neoplastic disease [31]. However, investigation of cancer incidence in a larger cohort of older animals was hampered by the fact that only a small fraction of these mice survived into adulthood [31].
We observed accelerated proliferation of Rnaseh2EKO epidermis, resulting in epidermal hyperplasia and thickening of the cornified layer (hyperkeratosis) despite greatly increased rates of keratinocyte apoptosis. An important inducer of apoptosis in Rnaseh2EKO skin was p53, since additional loss of p53 resulted in significant further acceleration of epithelial hyperproliferation. These rapid cell divisions in response to keratinocyte genome damage ensuing from RER deficiency likely reflect a response program that the epidermis executes upon exposure to multiple forms of DNA damage, aiming at improved light protection by increasing thickness of epidermis and cornified layer, associated with enhanced melanin production, as we also observed in our animals. This response is activated for example upon over-exposure to UV irradiation [45]. Enhanced epidermal proliferation upon genome damage also results in elimination of damaged cells through rapid epithelial turnover, which represents an alternative keratinocyte disposal pathway in addition to apoptosis [46]. Damaged basal cells arrest in late S-phase, detach from the basement membrane and get eliminated into the cornified layer [46].
Accelerated epithelial turnover in Rnaseh2EKO skin was associated with disturbed hair cycle regulation with progressive loss of hair follicle stem cells and hair follicle function. This might be a result of exhaustion of this stem cell population due to increased demand for differentiated keratinocytes, but may also reflect loss of hair follicle stem cells through apoptosis or terminal differentiation and transepidermal elimination. The latter was described to be the major cause for physiological hair follicle aging and for premature hair follicle deterioration enforced by ionizing irradiation or genetic defects of nucleotide excision repair [47]. Other epidermal stem cell populations were not reduced in numbers, likely reflecting differential responses to genome damage caused by defective RER. Specific responses of different stem cell populations to genome damage are documented in various tissues [48]. Hair follicle stem cells were found to be more resistant to cell death induction by ionizing irradiation compared to other epidermal stem cell populations due to their capability to rapidly repair double strand breaks by non-homologous end joining and high level expression of the anti-apoptotic protein Bcl2 [49]. Epidermis-specific inactivation of homologous recombination repair by conditional knock out of BRCA1, however, resulted in selective depletion of hair follicle stem cells [50], similar to the loss of hair follicle stem cells in our Rnaseh2EKO animals. In both mouse lines, loss of hair and hair follicle stem cells are largely rescued by additional inactivation of the Trp53 gene [50], indicating p53-dependent cell death induction by RER deficiency in these cells. Additional absence of p53 in Rnaseh2EKO mice not only restored stem cell numbers to control levels, but resulted in three-fold higher hair follicle stem cell numbers compared to RER competent controls, likely reflecting pre-neoplastic expansion of this population.
Rapid progression to cancer in 100% of the animals with epidermis-specific loss of RER activity, even despite intact p53 signaling, raises the question of whether mutations impairing RER are relevant for human cancer. However, the studies of cancer incidence in AGS patients carrying defects of RNASEH2 genes are hampered by their reduced life span [51].
Germline mutations compromising RER as well as somatic defects of RER acquired by growing tumor clones could affect tumor biology in two opposite ways. On one hand, DNA damage ensuing from unrepaired ribonucleotides causes genomic instability, thus promoting carcinogenesis and tumor progression. On the other hand, high rates of tumor cell death or senescence induction by persistent DNA lesions will antagonize malignant growth and can confer a competitive disadvantage to tumor cells. The net effect, tumor promotion or suppression, likely depends on the degree to which RER activity is reduced. A window of low RER activity advantageous for tumor growth may exist. The net effect of RER deficiency on cancer biology likely also depends on tumor type, as different cell types and cells of the same type but different differentiation stage show specific responses to DNA damage ranging from apoptosis and senescence to enforced differentiation [48, 52]. In addition to detection of damage by nuclear sensors likely occurring in RNase H2-deficient cells, micronucleus formation associated with RER deficiency and subsequent micronuclear envelope rupture were shown to lead to frequent exposure of chromosomal DNA to the cytosolic DNA sensor cGAS, resulting in the activation of STING [24]. STING is also activated upon DNA damage by herniation of chromatin into the cytosol [26]. The potent type I IFN response we observed in Rnaseh2EKO skin most likely reflects activation of the cGAS-STING axis. Potentiation of this IFN response in the absence of functional p53 strongly suggests that genome damage is responsible for STING activation in our animals, as lack of p53 allows cells with high damage load producing IFN to survive longer. STING can trigger differential responses, including senescence or apoptosis as well as antiviral and inflammatory cytokine production stimulating immune activation, depending on signal strength and cell type. RER-deficient epidermis invariably develops cancer despite robust STING activation and production of type IFN, which can strongly boost anti-tumor immunity [53]. Intriguingly, STING-mediated innate immune responses can also promote neoplastic growth, as STING activation by micronuclear DNA in chromosomally unstable cancer cells was recently shown to drive metastasis by activation of non-canonical NF-kB signaling [54].
Assessing contributions of RER defects to human cancer requires studies correlating frequencies of partial loss-of-function mutations in RNASEH2 genes, either in the germ-line or the tumor tissue of the patients, in particular cancer entities. Increased frequencies of RNASEH2B partial loss-of-function mutations were found in the germline of sporadic prostate cancer patients compared to control cohorts [55]. RNASEH2B partial loss-of-function mutations were also detected at higher frequencies in non-tumor DNA of glioma patients with familial cancer predisposition and co-segregated with manifestation of cancer in some of the families [55]. These findings provide first hints that compromised RER activity can be associated with human cancer.
Supplementary Material
Statement of Significance.
Selective inactivation of ribonucleotide excision repair by loss of RNase H2 in the murine epidermis results in spontaneous DNA damage, type I interferon response, skin inflammation, and development of squamous cell carcinoma.
Acknowledgements
We thank Tobias Häring for expert technical assistance.
The study was supported by grant 2015_A100 of the Else Kröner-Fresenius Foundation to A. Roers and R. Behrendt, by German Research Foundation (DFG) grant Ro2133/6–1 in the setting of Clinical Research Unit KFO249 to A. Roers. R. Behrendt is supported by the Aicardi-Goutières Syndrome Americas Association. Work in the laboratory of A.P. Jackson was supported by the Medical Research Council (MRC, U127580972).
Abbreviations:
- AGS
Aicardi-Goutières syndrome
- BMMRD
biallelic mismatch repair deficiency
- DDR
DNA damage response
- ISGs
interferon-stimulated genes
- KIN
keratinocyte intraepithelial neoplasia
- MMR
mismatch repair
- RER
ribonucleotide excision repair
- RNase H2
ribonuclease H2
- SCC
squamous cell carcinoma
Footnotes
The authors declare no potential conflicts of interest.
References
- 1.Hoeijmakers JH, DNA damage, aging, and cancer. N Engl J Med, 2009. 361(15): p. 1475–85. [DOI] [PubMed] [Google Scholar]
- 2.Lindahl T and Wood RD, Quality control by DNA repair. Science, 1999. 286(5446): p. 1897–905. [DOI] [PubMed] [Google Scholar]
- 3.Ganai RA and Johansson E, DNA Replication-A Matter of Fidelity. Mol Cell, 2016. 62(5): p. 745–55. [DOI] [PubMed] [Google Scholar]
- 4.Kunkel TA, Evolving views of DNA replication (in)fidelity. Cold Spring Harb Symp Quant Biol, 2009. 74: p. 91–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kunkel TA and Erie DA, Eukaryotic Mismatch Repair in Relation to DNA Replication. Annu Rev Genet, 2015. 49: p. 291–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lynch HT, et al. , Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer, 2015. 15(3): p. 181–94. [DOI] [PubMed] [Google Scholar]
- 7.Wimmer K and Etzler J, Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet, 2008. 124(2): p. 105–22. [DOI] [PubMed] [Google Scholar]
- 8.Nick McElhinny SA, et al. , Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci U S A, 2010. 107(11): p. 4949–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Joyce CM, Choosing the right sugar: how polymerases select a nucleotide substrate. Proc Natl Acad Sci U S A, 1997. 94(5): p. 1619–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Nick McElhinny SA, et al. , Genome instability due to ribonucleotide incorporation into DNA. Nat Chem Biol, 2010. 6(10): p. 774–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Traut TW, Physiological concentrations of purines and pyrimidines. Mol Cell Biochem, 1994. 140(1): p. 1–22. [DOI] [PubMed] [Google Scholar]
- 12.Reijns MA, et al. , Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell, 2012. 149(5): p. 1008–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Williams JS, Lujan SA, and Kunkel TA, Processing ribonucleotides incorporated during eukaryotic DNA replication. Nat Rev Mol Cell Biol, 2016. 17(6): p. 350–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sparks JL, et al. , RNase H2-initiated ribonucleotide excision repair. Mol Cell, 2012. 47(6): p. 980–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cerritelli SM and Crouch RJ, The Balancing Act of Ribonucleotides in DNA. Trends Biochem Sci, 2016. 41(5): p. 434–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lujan SA, et al. , Ribonucleotides are signals for mismatch repair of leading-strand replication errors. Mol Cell, 2013. 50(3): p. 437–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ghodgaonkar MM, et al. , Ribonucleotides misincorporated into DNA act as strand-discrimination signals in eukaryotic mismatch repair. Mol Cell, 2013. 50(3): p. 323–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Williams JS, et al. , Evidence that processing of ribonucleotides in DNA by topoisomerase 1 is leading-strand specific. Nat Struct Mol Biol, 2015. 22(4): p. 291–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Caldecott KW, Molecular biology. Ribose--an internal threat to DNA. Science, 2014. 343(6168): p. 260–1. [DOI] [PubMed] [Google Scholar]
- 20.Kim N, et al. , Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science, 2011. 332(6037): p. 1561–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Huang SN, et al. , Topoisomerase I-mediated cleavage at unrepaired ribonucleotides generates DNA double-strand breaks. EMBO J, 2017. 36(3): p. 361–373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Chon H, et al. , RNase H2 roles in genome integrity revealed by unlinking its activities. Nucleic Acids Res, 2013. 41(5): p. 3130–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hiller B, et al. , Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med, 2012. 209(8): p. 1419–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mackenzie KJ, et al. , cGAS surveillance of micronuclei links genome instability to innate immunity. Nature, 2017. 548(7668): p. 461–465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bartsch K, et al. , Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy. Hum Mol Genet, 2017. 26(20): p. 3960–3972. [DOI] [PubMed] [Google Scholar]
- 26.Gluck S, et al. , Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol, 2017. 19(9): p. 1061–1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Crow YJ, et al. , Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet, 2006. 38(8): p. 910–6. [DOI] [PubMed] [Google Scholar]
- 28.Crow YJ and Manel N, Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol, 2015. 15(7): p. 429–40. [DOI] [PubMed] [Google Scholar]
- 29.Reijns MA, et al. , The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease. J Biol Chem, 2011. 286(12): p. 10530–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chon H, et al. , Contributions of the two accessory subunits, RNASEH2B and RNASEH2C, to the activity and properties of the human RNase H2 complex. Nucleic Acids Res, 2009. 37(1): p. 96–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pokatayev V, et al. , RNase H2 catalytic core Aicardi-Goutieres syndrome-related mutant invokes cGAS-STING innate immune-sensing pathway in mice. J Exp Med, 2016. 213(3): p. 329–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mackenzie KJ, et al. , Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response. EMBO J, 2016. 35(8): p. 831–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hafner M, et al. , Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis, 2004. 38(4): p. 176–81. [DOI] [PubMed] [Google Scholar]
- 34.Jacks T, et al. , Tumor spectrum analysis in p53-mutant mice. Curr Biol, 1994. 4(1): p. 1–7. [DOI] [PubMed] [Google Scholar]
- 35.Jensen KB, Driskell RR, and Watt FM, Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat Protoc, 2010. 5(5): p. 898–911. [DOI] [PubMed] [Google Scholar]
- 36.Love MI, Huber W, and Anders S, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 2014. 15(12): p. 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Chang CH, et al. , CK1alpha ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. Proc Natl Acad Sci U S A, 2017. 114(38): p. E8035–E8044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cui R, et al. , Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell, 2007. 128(5): p. 853–64. [DOI] [PubMed] [Google Scholar]
- 39.Wenzel J and Tuting T, An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”. J Invest Dermatol, 2008. 128(10): p. 2392–402. [DOI] [PubMed] [Google Scholar]
- 40.Essers MA, et al. , IFNalpha activates dormant haematopoietic stem cells in vivo. Nature, 2009. 458(7240): p. 904–8. [DOI] [PubMed] [Google Scholar]
- 41.Kamphuis E, et al. , Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood, 2006. 108(10): p. 3253–61. [DOI] [PubMed] [Google Scholar]
- 42.Fernandez Figueras MT, From actinic keratosis to squamous cell carcinoma: pathophysiology revisited. J Eur Acad Dermatol Venereol, 2017. 31 Suppl 2: p. 5–7. [DOI] [PubMed] [Google Scholar]
- 43.Lee K, Tosti E, and Edelmann W, Mouse models of DNA mismatch repair in cancer research. DNA Repair (Amst), 2016. 38: p. 140–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rice G, et al. , Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet, 2007. 81(4): p. 713–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Sterenborg HJ, de Gruijl FR, and van der Leun JC, UV-induced epidermal hyperplasia in hairless mice. Photodermatol, 1986. 3(4): p. 206–14. [PubMed] [Google Scholar]
- 46.Stout GJ, et al. , Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: an alternative to in situ apoptosis. Proc Natl Acad Sci U S A, 2005. 102(52): p. 18980–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Matsumura H, et al. , Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science, 2016. 351(6273): p. aad4395. [DOI] [PubMed] [Google Scholar]
- 48.Blanpain C, et al. , DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell, 2011. 8(1): p. 16–29. [DOI] [PubMed] [Google Scholar]
- 49.Sotiropoulou PA, et al. , Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol, 2010. 12(6): p. 572–82. [DOI] [PubMed] [Google Scholar]
- 50.Sotiropoulou PA, et al. , BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny. Genes Dev, 2013. 27(1): p. 39–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Crow YJ, et al. , Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A, 2015. 167A(2): p. 296–312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lans H and Vermeulen W, Tissue specific response to DNA damage: C. elegans as role model. DNA Repair (Amst), 2015. 32: p. 141–8. [DOI] [PubMed] [Google Scholar]
- 53.Zitvogel L, et al. , Type I interferons in anticancer immunity. Nat Rev Immunol, 2015. 15(7): p. 405–14. [DOI] [PubMed] [Google Scholar]
- 54.Bakhoum SF, et al. , Chromosomal instability drives metastasis through a cytosolic DNA response. Nature, 2018. 553(7689): p. 467–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Beyer U, et al. , Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis. Acta Neuropathol, 2017. 134(6): p. 905–922. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.